Observational study on the evaluation of quality of life in patients affected by enteropathic spondyloarthritis
Corresponding Author
Maria Sole Chimenti
Rheumatology Unit, Allergology and Clinical Immunology, Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy
Correspondence
Maria Sole Chimenti, Rheumatology Unit, Allergology and Clinical Immunology, Department of Systems Medicine, University of Rome Tor Vergata, Via Montpellier 1, Rome, Italy.
Email: maria.sole.chimenti@uniroma2.it
Search for more papers by this authorPaola Conigliaro
Rheumatology Unit, Allergology and Clinical Immunology, Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy
Search for more papers by this authorBarbara Polistena
Department of Economic and Finance, University of Rome Tor Vergata, C.R.E.A. Sanità (Consortium for Applied Economic Research in Healthcare), Rome, Italy
Search for more papers by this authorPaola Triggianese
Rheumatology Unit, Allergology and Clinical Immunology, Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy
Search for more papers by this authorArianna D'Antonio
Rheumatology Unit, Allergology and Clinical Immunology, Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy
Search for more papers by this authorBenedetto Neri
GI Unit, Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy
Search for more papers by this authorGiorgia Sena
GI Unit, Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy
Search for more papers by this authorFederico Spandonaro
Department of Economic and Finance, University of Rome Tor Vergata, C.R.E.A. Sanità (Consortium for Applied Economic Research in Healthcare), Rome, Italy
Search for more papers by this authorLivia Biancone
GI Unit, Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy
Search for more papers by this authorRoberto Perricone
Rheumatology Unit, Allergology and Clinical Immunology, Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy
Search for more papers by this authorCorresponding Author
Maria Sole Chimenti
Rheumatology Unit, Allergology and Clinical Immunology, Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy
Correspondence
Maria Sole Chimenti, Rheumatology Unit, Allergology and Clinical Immunology, Department of Systems Medicine, University of Rome Tor Vergata, Via Montpellier 1, Rome, Italy.
Email: maria.sole.chimenti@uniroma2.it
Search for more papers by this authorPaola Conigliaro
Rheumatology Unit, Allergology and Clinical Immunology, Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy
Search for more papers by this authorBarbara Polistena
Department of Economic and Finance, University of Rome Tor Vergata, C.R.E.A. Sanità (Consortium for Applied Economic Research in Healthcare), Rome, Italy
Search for more papers by this authorPaola Triggianese
Rheumatology Unit, Allergology and Clinical Immunology, Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy
Search for more papers by this authorArianna D'Antonio
Rheumatology Unit, Allergology and Clinical Immunology, Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy
Search for more papers by this authorBenedetto Neri
GI Unit, Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy
Search for more papers by this authorGiorgia Sena
GI Unit, Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy
Search for more papers by this authorFederico Spandonaro
Department of Economic and Finance, University of Rome Tor Vergata, C.R.E.A. Sanità (Consortium for Applied Economic Research in Healthcare), Rome, Italy
Search for more papers by this authorLivia Biancone
GI Unit, Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy
Search for more papers by this authorRoberto Perricone
Rheumatology Unit, Allergology and Clinical Immunology, Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy
Search for more papers by this authorMaria Sole Chimenti and Paola Conigliaro contributed equally to this study.
Abstract
Background
Enteropathic spondyloarthritis (ESpA) and inflammatory bowel diseases (IBD) have high impact on physical and psychological health but health-related quality of life (HRQoL) has never been evaluated in ESpA patients.
Purpose
Cross-sectional multidisciplinary study was performed to evaluate HRQoL, state of health, and well-being in IBD and ESpA patients.
Methods
Consecutive IBD and ESpA outpatients were enrolled. Disease activity, inflammatory parameters, function, and quality of life (EuroQol questionnaire) were assessed at visit time and compared with 12 months ago.
Results
Two hundred fifty-three IBD patients were evaluated. Ninety-five patients met inclusion criteria. ESpA was established in 65.3% IBD patients. Most ESpA patients had discreet or good health perception (65.3% and 22.5%, respectively), similar to IBD group (64.6% and 20.7%, respectively). In both groups, no patients had exceptional state of general well-being. Compared with previous 12 months, ESpA group showed improved state of health in 12% of patients, worsening in 28% and stable state of health in 60%. Similar results were obtained in IBD group. Emotional and psychological problems (anxiety, depression, and feeling of loneliness and isolation) were reported: In ESpA patients, these feelings were observed in 58.1%, 40.57%, and 29% of cases, respectively; IBD patients showed slightly lower percentage. More than half of ESpA and IBD patients reported an embarrassment about their condition and worry about disease's future progression and physical pain.
Conclusions
Well-being, quality of life, and psychological problems were described in ESpA and IBD patients. Disease management should include also social, mental, and psychological impacts, in terms of QoL.
CONFLICT OF INTEREST
The authors declare no conflict of interest.
REFERENCES
- Balestroni, G., & Bertolotti, G. (2012). EuroQol-5D (EQ-5D): An instrument for measuring quality of life. Monaldi Archives for Chest Disease, 78, 155–159. https://doi.org/10.4081/monaldi.2012.121
- Bernklev, T., Jahnsen, J., Lygren, I., Henriksen, M., Vatn, M., & Moum, B. (2005). Health-related quality of life in patients with inflammatory bowel disease measured with the short form-36: Psychometric assessments and a comparison with general population norms. Inflammatory Bowel Diseases, 11, 909–918. https://doi.org/10.1097/01.mib.0000179467.01748.99
- Burckhardt, C. S., & Anderson, K. L. (2003). The quality of life scale (QOLS): Reliability, validity, and utilization. Health and Quality of Life Outcomes, 1, 60. https://doi.org/10.1186/1477-7525-1-60
- Colonnello, V., & Agostini, A. (2020). Disease course, stress, attachment, and mentalization in patients with inflammatory bowel disease. Medical Hypotheses, 140, 109665. https://doi.org/10.1016/j.mehy.2020
- Elolemy, G., Aboughanima, A., Ganeb, S., & Elziat, H. (2019). Health-related quality of life in patients with ankylosing spondylitis: Relationship with disease-related variables. Current Rheumatology Reviews, 15, 1–8. https://doi.org/10.2174/1573397115666191018162606
- Fortune, D. G., Richards, H. L., & Griffiths, C. E. (2005). Psychologic factors in psoriasis: consequences, mechanisms, and interventions. Dermatologic Clinics, 23, 681–694. https://doi.org/10.1016/j.det.2005.05.022
- Fragoulis, G. E., Liava, C., Daoussis, D., Akriviadis, E., Garyfallos, A., & Dimitroulas, T. (2019). Inflammatory bowel diseases and spondyloarthropathies: From pathogenesis to treatment. World Journal of Gastroenterology, 25, 2162–2176. https://doi.org/10.3748/wjg.v25.i18.2162
- Girolomoni, G., Pserico, A., Altomare, G., Ayala, F., Berardesca, E., & Calzavara-Pinton, P. (2013). Quality of life in patients with plaque psoriasis treated with biologic therapies. Clinical Dermatology, 1, 175–182. https://doi.org/10.11138/CDERM/2013.1.4.175
- Gomollón, F., Dignass, A., Annese, V., Tilg, H., van Assche, G., Lindsay, J. O., … ECCO. (2017). 3rd European evidence-based consensus on the diagnosis and management of Crohn's disease 2016: Part 1: Diagnosis and medical management. Journal of Crohn's & Colitis, 11, 3–25. https://doi.org/10.1093/ecco-jcc/jjw168
- Habibi, F., Habibi, M. E., Gharavinia, A., Mahdavi, S. B., Akbarpour, M. J., Baghaei, A., & Emami, M. H. (2017). Quality of life in inflammatory bowel disease patients: A cross-sectional study. Journal of Research in Medical Sciences : The Official Journal of Isfahan University of Medical Sciences, 22, 104. https://doi.org/10.4103/jrms.JRMS_975_16
- Ho, P. Y. M., Hu, W., Lee, Y. Y., Gao, C., Tan, Y. Z., Cheen, M., … Ong, W. C. (2019). Health-related quality of life of patients with inflammatory bowel disease in Singapore. Intestinal Research, 17, 107–118. https://doi.org/10.5217/ir.2018.00099
- Huppertz-Hauss, G., Høivik, M. L., Langholz, E., Odes, S., Småstuen, M., Stockbrugger, R., … Bernklev, T. (2015). Health-related quality of life in inflammatory bowel disease in a European-wide population-based cohort 10 years after diagnosis. Inflammatory Bowel Diseases, 21, 337–344. https://doi.org/10.1097/MIB.0000000000000272
- Keightley, P., Reay, R. E., Pavli, P., & Looi, J. C. (2018). Inflammatory bowel disease-related fatigue is correlated with depression and gender. Australasian Psychiatry, 26, 508–513. https://doi.org/10.1177/1039856218772245
- Kiltz, U., van der Heijde, D., Boonen, A., Cieza, A., Stucki, G., Khan, M. A., … Braun, J. (2015). Development of a health index in patients with ankylosing spondylitis (ASAS HI): Final result of a global initiative based on the ICF guided by ASAS. Annals of the Rheumatic Diseases, 74, 830–835. https://doi.org/10.1136/annrheumdis-2013-203967
- Maaser, C., Sturm, A., Vavricka, S. R., Kucharzik, T., Fiorino, G., Annese, V., … European Crohn’s and Colitis Organisation [ECCO] and the European Society of Gastrointestinal and Abdominal Radiology [ESGAR]. (2019). ECCO-ESGAR guideline for diagnostic assessment in IBD Part 1: Initial diagnosis, monitoring of known IBD, detection of complications. Journal of Crohn's & Colitis, 13, 144–164. https://doi.org/10.1093/ecco-jcc/jjy113
- Magro, F., Gionchetti, P., Eliakim, R., Ardizzone, S., Armuzzi, A., Barreiro-de Acosta, M., … European Crohn's and Colitis Organisation [ECCO]. ECCO and ESGAR. (2017). 3rd European evidence-based consensus on diagnosis and management of ulcerative colitis: Part 1: Definitions, diagnosis, extra-intestinal manifestations, pregnancy, cancer surveillance, surgery, and ileo-anal pouch disorders. Journal of Crohn's & Colitis, 11, 649–670. https://doi.org/10.1093/ecco-jcc/jjy113
- Miller, A. H., Maletic, V., & Raison, C. L. (2009). Inflammation and its discontents: The role of cytokines in the pathophysiology of major depression. Biological Psychiatry, 65, 732–741. https://doi.org/10.1016/j.biopsych.2008.11.029
- Neuendorf, R., Harding, A., Stello, N., Hanes, D., & Wahbeh, H. (2016). Depression and anxiety in patients with inflammatory bowel disease: A systematic review. Journal of Psychosomatic Research, 87, 70–80. https://doi.org/10.1016/j.jpsychores.2016.06.001
- Nikiphorou, E., Ramiro, S., van der Heijde, D., Norton, S., Moltó, A., Dougados, M., … Assessment of SpondyloArthritis International Society Comorbidities in Spondyloarthritis Study Task Force. (2018). Association of comorbidities in spondyloarthritis with poor function, work disability, and quality of life: Results from the assessment of spondyloarthritis international society comorbidities in spondyloarthritis study. Arthritis Care & Research (Hoboken), 70, 1257–1262. https://doi.org/10.1002/acr.23468
- Picchianti-Diamanti, A., Lorenzetti, R., Chimenti, M. S., Luchetti, M. M., Conigliaro, P., Canofari, C., … Zullo, A. (2020). Enteropathic spondyloarthritis: Results from a large nationwide database analysis. Autoimmunity Reviews, 19(2), 102457. https://doi.org/10.1016/j.autrev.2019.102457
- Rabin, R., & de Charro, F. (2001). EQ-5D: A measure of health status from the EuroQol Group. Annals of Medicine, 33, 337–343. https://doi.org/10.3109/07853890109002087
- Rodrigues, J., Rodrigues, A. M., Dias, S. S., Sousa, R. D., Branco, J. C., & Canhão, H. (2019). Psoriatic arthritis and ankylosing spondylitis impact on health-related quality of life and working life: A comparative population-based study. Acta Reumatológica Portuguesa, 44, 254–265.
- Rudwaleit, M., van der Heijde, D., Landewé, R., Akkoc, N., Brandt, J., Chou, C. T., … Sieper, J. (2011). The assessment of spondyloarthritis international society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general. Annals of the Rheumatic Diseases, 70, 25–31. https://doi.org/10.1136/ard.2010.133645
- Sajadinejad, M. S., Asgari, K., Molavi, H., Kalantari, M., & Adibi, P. (2012). Psychological issues in inflammatory bowel disease: An overview. Gastroenterology Research and Practice, 2012, 1–11, 106502. https://doi.org/10.1155/2012/106502
- Salaffi, F., Carotti, M., Gasparini, S., Intorcia, M., & Grassi, W. (2009). The health-related quality of life in rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis: A comparison with a selected sample of health people. Health and Quality of Life Outcomes, 7, 25https://doi.org/10.1186/1477-7525-7-25
- Smolen, J. S., Breedveld, F. C., Burmester, G. R., Bykerk, V., Dougados, M., Emery, P., … van der Heijde, D. (2014). Treating spondyloarthritis, including ankylosing spondylitis and psoriatic arthritis, to target: Recommendations of an international task force. Annals of the Rheumatic Diseases, 73, 6–16. https://doi.org/10.1136/annrheumdis-2017-211734
- Terenzi, R., Monti, S., Tesei, G., & Carli, L. (2018). One year in review 2017: Spondyloarthritis. Clinical and Experimental Rheumatology, 36(1), 1–14.
- Testa, M. A., & Simonson, D. C. (1996). Assessment of quality of life outcomes. The New England Journal of Medicine, 28, 835–840. https://doi.org/10.1056/NEJM199603283341306
- Timmer, A., Preiss, J. C., Motschall, E., Rucker, G., Jantschek, G., & Moser, G. (2011). Psychological interventions for treatment of inflammatory bowel disease. Cochrane Database of Systematic Reviews, 16, 1–136. https://doi.org/10.1002/14651858.CD006913
- Tsang, H. H. L., Cheung, J. P. Y., Wong, C. K. H., Cheung, P. W. H., Lau, C. S., & Chung, H. Y. (2019). Psychometric validation of the EuroQoL 5-dimension (EQ-5D) questionnaire in patients with spondyloarthritis. Arthritis Research & Therapy, 21(1), 1–41.
- van der Heijde, D., Ramiro, S., Landewé, R., Baraliakos, X., van den Bosch, F., Sepriano, A., … van Gaalen, F. (2017). 2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis. Annals of the Rheumatic Diseases, 76, 978–991. https://doi.org/10.1186/s13075-019-1826-x
- World Health Organization. (1980). International classification of impairments, disabilities and handicaps (ICIDH): A manual of classification relating to the consequences of disease. World Health Organization.
- Zhao, S. S., Thong, D., Miller, N., Duffield, S. J., Hughes, D. M., Chadwick, L., & Goodson, N. J. (2018). The prevalence of depression in axial spondyloarthritis and its association with disease activity: A systematic review and meta-analysis. Arthritis Research & Therapy, 20(1), 140. https://doi.org/10.1186/s13075-018-1644-6
